4NJ3 | Modulating the interaction between CDK2 and Cyclin A with a Quinoline-based inhibitor | date | 2013-11-08 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | Fischmann, T.O., Hruza, A.W. | ||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 1.85 | ||||||||||||
ligand | 2KD, ACE, CSD | enzyme |
| ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Modulating the interaction between CDK2 and cyclin A with a quinoline-based inhibitor., Deng Y, Shipps GW Jr, Zhao L, Siddiqui MA, Popovici-Muller J, Curran PJ, Duca JS, Hruza AW, Fischmann TO, Madison VS, Zhang R, McNemar CW, Mayhood TW, Syto R, Annis A, Kirschmeier P, Lees EM, Parry DA, Windsor WT, Bioorg Med Chem Lett. 2014 Jan 1;24(1):199-203. doi: 10.1016/j.bmcl.2013.11.041. , Epub 2013 Nov 23. PMID:24332088 |
Data retrieval |
View 4NJ3 in 3D |
Visual 3D analysis of 4NJ3 |
Structure-derived information |
Sequence-derived information |
Other resources with information on 4NJ3 |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |